PubRank

Jean-Luc Pellegrin

Author PubWeight™ 45.65‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. J Acquir Immune Defic Syndr 2007 3.38
2 Granulomatosis-associated common variable immunodeficiency disorder: a case-control study versus sarcoidosis. Eur Respir J 2012 2.11
3 Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus. Sci Transl Med 2010 1.83
4 Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 2005 1.49
5 Microbiologic characteristics and in vitro susceptibility to antimicrobials in a large population of patients with cardiovascular implantable electronic device infection. J Cardiovasc Electrophysiol 2011 1.42
6 Virological, intracellular and plasma pharmacological parameters predicting response to lopinavir/ritonavir (KALEPHAR study). AIDS 2004 1.35
7 Virological responses to atazanavir-ritonavir-based regimens: resistance-substitutions score and pharmacokinetic parameters (Reyaphar study). Antivir Ther 2006 1.19
8 Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement. Ann Med 2002 1.17
9 Virologic response to nelfinavir-based regimens: pharmacokinetics and drug resistance mutations (VIRAPHAR study). AIDS 2002 1.11
10 Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis. Arthritis Rheum 2007 1.09
11 Platelet-associated CD154 in immune thrombocytopenic purpura. Blood 2004 1.03
12 Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis. Blood 2002 1.02
13 Predictive value of provirus load and DNA human immunodeficiency virus genotype for successful abacavir-based simplified therapy. J Infect Dis 2002 1.00
14 Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France. Clin Infect Dis 2005 0.98
15 Effect of cytomegalovirus-induced immune response, self antigen-induced immune response, and microbial translocation on chronic immune activation in successfully treated HIV type 1-infected patients: the ANRS CO3 Aquitaine Cohort. J Infect Dis 2012 0.96
16 Thymoma-associated neuromyotonia with antibodies against voltage-gated potassium channels presenting as chronic intestinal pseudo-obstruction. Eur Neurol 2005 0.95
17 Interpretation of genotype and pharmacokinetics for resistance to fosamprenavir-ritonavir-based regimens in antiretroviral-experienced patients. Antimicrob Agents Chemother 2007 0.94
18 CD8+HLA-DR+ T lymphocytes are increased in common variable immunodeficiency patients with impaired memory B-cell differentiation. Clin Immunol 2006 0.93
19 Virological response to darunavir/ritonavir-based regimens in antiretroviral-experienced patients (PREDIZISTA study). Antivir Ther 2008 0.89
20 Successful cidofovir therapy of progressive multifocal leukoencephalopathy preceding angioimmunoblastic T-cell lymphoma. Leuk Lymphoma 2005 0.89
21 Cytotoxic T lymphocytes and autoimmunity. Curr Opin Rheumatol 2005 0.88
22 Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: a case-control study. J Hepatol 2010 0.87
23 Borna disease virus RNA in immunocompromised patients in southwestern France. J Clin Microbiol 2003 0.85
24 [Subacute necrotizing lymphadenitis or Kikuchi-Fujimoto disease]. Presse Med 2007 0.85
25 Risk factors for hyperlactataemia in HIV-infected patients, Aquitaine Cohort, 1999--2003. Antivir Chem Chemother 2005 0.85
26 Altered dendritic cell distribution in patients with common variable immunodeficiency. Arthritis Res Ther 2005 0.83
27 HIV type-1 transmission dynamics in recent seroconverters: relationship with transmission of drug resistance and viral diversity. Antivir Ther 2009 0.83
28 [Large granular lymphocyte leukemia]. Presse Med 2007 0.82
29 Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus. Expert Opin Pharmacother 2010 0.82
30 Crow-Fukase (POEMS) syndrome: a study of peripheral nerve biopsy in five new cases. J Peripher Nerv Syst 2003 0.81
31 Reversible myelofibrosis induced by tuberculosis. Clin Infect Dis 2002 0.81
32 Myocarditis in Patients With Antisynthetase Syndrome: Prevalence, Presentation, and Outcomes. Medicine (Baltimore) 2015 0.81
33 Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection. Antivir Ther 2006 0.80
34 Activation of mesangial cells by platelets in systemic lupus erythematosus via a CD154-dependent induction of CD40. Kidney Int 2005 0.79
35 Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study. Arthritis Res Ther 2010 0.79
36 Gammadelta T lymphocytosis associated with granulomatous disease in a patient with common variable immunodeficiency. Clin Infect Dis 2002 0.79
37 Can highly active antiretroviral therapy be interrupted in patients with sustained moderate HIV RNA and > 400 CD4+ cells/microl? Impact on immunovirological parameters. J Med Virol 2005 0.78
38 Intracellular and plasma efavirenz concentrations in HIV-infected patients switching from successful protease inhibitor-based highly active antiretroviral therapy (HAART) to efavirenz-based HAART (SUSTIPHAR Study). J Antimicrob Chemother 2006 0.78
39 [Platelet-associated CD154: a new interface in haemostasis and in the inflammatory reaction]. Med Sci (Paris) 2005 0.78
40 Lower 12-hour trough concentrations of mycophenolic acid in patients with active systemic vasculitides taking mycophenolate mofetil. J Rheumatol 2012 0.78
41 [Choice of career by French medical students after the national ranking exam in 2012]. Presse Med 2013 0.78
42 Romiplostim as early treatment for refractory primary immune thrombocytopenia. Int J Hematol 2013 0.76
43 Expansion of myelin autoreactive CD8+ T lymphocytes in patients with neuropsychiatric systemic lupus erythematosus. Ann Rheum Dis 2010 0.76
44 Alternative methods to analyse the impact of HIV mutations on virological response to antiviral therapy. BMC Med Res Methodol 2008 0.76
45 Pre-dose plasma concentration monitoring of mycophenolate mofetil in patients with autoimmune diseases. Br J Clin Pharmacol 2014 0.75
46 Glomerulonephritis caused by Actinobacillus actinomycetemcomitans mimicking c-ANCA-positive vasculitis. Nephrol Dial Transplant 2002 0.75
47 A sensitive liquid chromatography coupled with mass spectrometry method for the intracellular and plasma quantification of raltegravir after solid-phase extraction. J Pharm Pharmacol 2011 0.75
48 Chronic eosinophilic pneumonia presenting with pericarditis and ventricular wall hypertrophy. Int J Cardiol 2003 0.75
49 [When to suspect immunologic deficiency?]. Rev Prat 2007 0.75
50 Severe prolonged red blood cell aplasia and thrombocytopenia induced by parvovirus B19 infection in a patient with sarcoidosis. Clin Infect Dis 2003 0.75
51 [Thrombocytosis: adverse effect of heparin treatment]. Presse Med 2006 0.75
52 [Utility of the bone marrow biopsy in the diagnosis of essential thrombocytemia]. Presse Med 2011 0.75
53 [Pathophysiology of systemic lupus erythematosus]. Presse Med 2007 0.75
54 Bone-marrow fibrin-ring granuloma. Lancet 2003 0.75